Altomare, D; de Wilde, A; Ossenkoppele, R; Pelkmans, W; Bouwman, F; Groot, C; van Maurik, I; ... van der Flier, WM; + view all Altomare, D; de Wilde, A; Ossenkoppele, R; Pelkmans, W; Bouwman, F; Groot, C; van Maurik, I; Zwan, M; Yaqub, M; Barkhof, F; van Berckel, BN; Teunissen, CE; Frisoni, GB; Scheltens, P; van der Flier, WM; - view fewer (2019) Applying the ATN scheme in a memory clinic population: The ABIDE project. Neurology , 93 (17) e1635-e1646. 10.1212/WNL.0000000000008361.

Text Barkhof Altomare_ATN stage in ABIDE_Neurology_R2_Manuscript_Clean.pdf - Accepted Version Access restricted to UCL open access staff Download (1MB)

Abstract

Objective To apply the ATN scheme to memory clinic patients, to assess whether it discriminates patient populations with specific features. Methods We included 305 memory clinic patients (33% subjective cognitive decline [SCD]: 60 ± 9 years, 61% M; 19% mild cognitive impairment [MCI]: 68 ± 9 years, 68% M; 48% dementia: 66 ± 10 years, 58% M) classified for positivity (±) of amyloid (A) ([18F]Florbetaben PET), tau (T) (CSF p-tau), and neurodegeneration (N) (medial temporal lobe atrophy). We assessed ATN profiles' demographic, clinical, and cognitive features at baseline, and cognitive decline over time. Results The proportion of A+T+N+ patients increased with syndrome severity (from 1% in SCD to 14% in MCI and 35% in dementia), while the opposite was true for A−T−N− (from 48% to 19% and 6%). Compared to A−T−N−, patients with the Alzheimer disease profiles (A+T+N− and A+T+N+) were older (both p < 0.05) and had a higher prevalence of APOE ε4 (both p < 0.05) and lower Mini-Mental State Examination (MMSE) (both p < 0.05), memory (both p < 0.05), and visuospatial abilities (both p < 0.05) at baseline. Non-Alzheimer profiles A−T−N+ and A-T+N+ showed more severe white matter hyperintensities (both p < 0.05) and worse language performance (both p < 0.05) than A−T−N−. A linear mixed model showed faster decline on MMSE over time in A+T+N− and A+T+N+ (p = 0.059 and p < 0.001 vs A−T−N−), attributable mainly to patients without dementia. Conclusions The ATN scheme identified different biomarker profiles with overlapping baseline features and patterns of cognitive decline. The large number of profiles, which may have different implications in patients with vs without dementia, poses a challenge to the application of the ATN scheme.

Download activity - last month

Export as JSONXMLCSV

Download activity - last 12 months

Export as JSONCSVXML

Downloads by country - last 12 months

Export as JSONXMLCSV

Archive Staff Only

View Item